From a research point of view, placebos are often essential in determining the safety and efficacy of a treatment. On the other hand, research

From a research point of view, placebos are often essential in determining the safety and efficacy of a treatment. On the other hand, research participants often hope they get active treatment, especially if it is for a disease they already have or might get.

Is it “fair” to research participants to randomly assign them to receive either an active drug or an inactive substance? What about someone with a terminal illness, and the research drug is their last chance? What can be done to make the situation “more fair”?

Share This Post

Email
WhatsApp
Facebook
Twitter
LinkedIn
Pinterest
Reddit

Order a Similar Paper and get 15% Discount on your First Order

Related Questions

see attachment  Readings PBS. (2006). Early christians . The Roman Empire in the first century. Devillier Donegan Enterprises. 

see attachment  Readings PBS. (2006). Early christians . The Roman Empire in the first century. Devillier Donegan Enterprises.  to an external site. Smith, H. (2020, December 08).  Gothic cathedrals: Architecture & divine light. World History Encyclopedia.   to an external site. Multimedia BBC Worldwide Learning. (2010).  Republic of virtue: Ancient worlds [Video]. Films On Demand.